Clinical Research
BibTex RIS Cite
Year 2022, Volume: 13 Issue: 4, 470 - 475, 01.10.2022
https://doi.org/10.31067/acusaglik.1158704

Abstract

References

  • 1. Zimmon, D. S. (1975). The clinical value of endoscopic retrograde cholangiopancreatography. Bulletin of the New York Academy of Medicine, 51(4), 472.
  • 2. Albert, J. G., & Riemann, J. F. (2002). ERCP and MRCP–when and why. Best Practice & Research Clinical Gastroenterology, 16(3), 399-41
  • 3. Ahmed, M., Kanotra, R., Savani, G. T., Kotadiya, F., Patel, N., Tareen, S., ... & Das, A. (2017). Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience. Endoscopy International Open, 5(04), E261-E271.
  • 4. Chandrasekhara, V., Khashab, M. A., Muthusamy, V. R., Acosta, R. D., Agrawal, D., Bruining, D. H., ... & DeWitt, J. M. (2017). Adverse events associated with ERCP. Gastrointestinal endoscopy, 85(1), 32-47.
  • 5. Anderson, M. A., Fisher, L., Jain, R., Evans, J. A., Appalaneni, V., Ben-Menachem, T., ... & Dominitz, J. A. (2012). Complications of ERCP. Gastrointestinal endoscopy, 75(3), 467-473.
  • 6. Loperfido, S., Angelini, G., Benedetti, G., Chilovi, F., Costan, F., De Berardinis, F., ... & Fratton, A. (1998). Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointestinal endoscopy, 48(1), 1-10.
  • 7. Cotton, P. B. (2001). ERCP is most dangerous for people who need it least. Gastrointestinal endoscopy, 54(4), 535-536. https://doi.org/10.1067/mge.2001.118446
  • 8. Freeman, M. L., DiSario, J. A., Nelson, D. B., Fennerty, M. B., Lee, J. G., Bjorkman, D. J., ... & Roel, J. P. (2001). Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointestinal endoscopy, 54(4), 425-434.
  • 9. Cotton P. B. (1977). ERCP. Gut, 18(4), 316–341. https://doi.org/10.1136/gut.18.4.316
  • 10. Søreide K, Hallet J, Matthews JB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;107(10):1250-1261. doi:10.1002/bjs.11670
  • 11. Voiosu T, Voiosu A, Boškoski I, et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol. 2020;13:1756284820980671. Published 2020 Dec 21. doi:10.1177/1756284820980671
  • 12. Soetikno, R., Teoh, A. Y., Kaltenbach, T., Lau, J. Y., Asokkumar, R., Cabral-Prodigalidad, P., & Shergill, A. (2020). Considerations in performing endoscopy during the COVID-19 pandemic. Gastrointestinal endoscopy, 92(1), 176-183.
  • 13. Resál, T., Bor, R., Szántó, K., Fábián, A., Rutka, M., Sacco, M., Ribaldone, D. G., Molander, P., Nancey, S., Kopylov, U., Vavricka, S., Drobne, D., Lukas, M., Farkas, K., Szepes, Z., & Molnár, T. (2021). Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. Therapeutic advances in gastroenterology, 14, 17562848211006678. https://doi.org/10.1177/17562848211006678
  • 14. Tag-Adeen M, Yousef M, Osman H, et al. Impact of COVID-19 pandemic on endoscopic retrograde cholangiopancreatography; a single center experience [published online ahead of print, 2021 Oct 26]. Rev Esp Enferm Dig. 2021;10.17235/reed.2021.8229/2021. doi:10.17235/reed.2021.8229/2021
  • 15. John O’Grady, Jan Leyden, Padraic MacMathuna, Stephen Stewart & T. Barry Kelleher (2020) ERCP and SARS-COV-2: an urgent procedure that should be immune, Scandinavian Journal of Gastroenterology, 55:8, 976-978, DOI: 10.1080/00365521.2020.1789210
  • 16. Layton GR, Chung WY, Isherwood J, et al. Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units. Br J Surg. 2021;108(9):e290-e291. doi:10.1093/bjs/znab161
  • 17. Lauro A, Pagano N, Impellizzeri G, Cervellera M, Tonini V. Emergency Endoscopy During the SARS-CoV-2 Pandemic in the North of Italy: Experience from St. Orsola University Hospital-Bologna. Dig Dis Sci. 2020;65:1559–1561.
  • 18. Repici A, Pace F, Gabbiadini R, Colombo M, Hassan C, Dinelli M ITALIAN GI-COVID19 Working Group. Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy. Gastroenterology. 2020;159:363–366.e3.
  • 19. Kim KH, Kim SB. Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea: Retrospective survey. World J Clin Cases. 2021;9(28):8404-8412. doi:10.12998/wjcc.v9.i28.8404
  • 20. Donato G, Forti E, Mutignani M, et al. A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy. Endosc Int Open. 2021;9(4):E629-E634. doi:10.1055/a-1380-3419
  • 21. Kim KH, Kim SB, Kim TN. Changes in endoscopic patterns before and during COVID-19 outbreak: Experience at a single tertiary center in Korean. World J Clin Cases. 2021;9(15):3576-3585. doi:10.12998/wjcc.v9.i15.3576

Covid-19: A Retrospective Study About The Challenges for ERCP?

Year 2022, Volume: 13 Issue: 4, 470 - 475, 01.10.2022
https://doi.org/10.31067/acusaglik.1158704

Abstract

NTRODUCTION: We aimed to investigate the effects of Covid-19 on Endoscopic retrograde cholangiopancreatography (ERCP) and to investigate what should be considered in the next possible epidemic situations.
METHODS: In our study, patients who applied to XXX University School of Medicine, Department of General Surgery for ERCP (Endoscopic retrograde cholangiopancreatography) between March 2019 and March 2021 were evaluated, retrospectively. Percentages, mean, standard deviation, median and interquartile range were used as the descriptive statistics. Mann-Whitney U test was used for the variations which are contrary to the normal distribution range in the comparison of two groups. The relations between qualitative variations were studied by the Pearson Chi-Square test and Fisher's Exact test. Significant value was determined as 0.05 for all statistical analyses.
RESULTS: Prior to COVID-19, ERCP indications were in the order of stone (90.1%), stent removal (8%) and tumor (1.1%), while in the period of COVID-19, the ranking changed to stone (73.8%), tumor (13.7%), and stent removal (12.4%).. The diagnostic use of ERCP has been greatly reduced (from 0.7% to 0.0%). No perforation was detected in both periods, there was no bleeding, but a small increase (4.7% to 5.9%) was found in pancreatitis in the COVID-19 period. In the pre-COVID-19 period, stones were detected in 46.2% of the patients and all of them were successfully removed, but during the COVID-19 period, stones were detected in 50.6% of the patients and the stones could not be removed in 1.3% of the patients.
DISCUSSION AND CONCLUSION: It was observed that the number of ERCPs decreased due to the delay in admissions to the hospital and the fear of coming to the hospital during the Covid-19 epidemic period, and the number of malignancies diagnosed with ERCP increased in this process. In such epidemic periods, more scheduled health services will provide better results for both patients and health personnel.

References

  • 1. Zimmon, D. S. (1975). The clinical value of endoscopic retrograde cholangiopancreatography. Bulletin of the New York Academy of Medicine, 51(4), 472.
  • 2. Albert, J. G., & Riemann, J. F. (2002). ERCP and MRCP–when and why. Best Practice & Research Clinical Gastroenterology, 16(3), 399-41
  • 3. Ahmed, M., Kanotra, R., Savani, G. T., Kotadiya, F., Patel, N., Tareen, S., ... & Das, A. (2017). Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience. Endoscopy International Open, 5(04), E261-E271.
  • 4. Chandrasekhara, V., Khashab, M. A., Muthusamy, V. R., Acosta, R. D., Agrawal, D., Bruining, D. H., ... & DeWitt, J. M. (2017). Adverse events associated with ERCP. Gastrointestinal endoscopy, 85(1), 32-47.
  • 5. Anderson, M. A., Fisher, L., Jain, R., Evans, J. A., Appalaneni, V., Ben-Menachem, T., ... & Dominitz, J. A. (2012). Complications of ERCP. Gastrointestinal endoscopy, 75(3), 467-473.
  • 6. Loperfido, S., Angelini, G., Benedetti, G., Chilovi, F., Costan, F., De Berardinis, F., ... & Fratton, A. (1998). Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointestinal endoscopy, 48(1), 1-10.
  • 7. Cotton, P. B. (2001). ERCP is most dangerous for people who need it least. Gastrointestinal endoscopy, 54(4), 535-536. https://doi.org/10.1067/mge.2001.118446
  • 8. Freeman, M. L., DiSario, J. A., Nelson, D. B., Fennerty, M. B., Lee, J. G., Bjorkman, D. J., ... & Roel, J. P. (2001). Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointestinal endoscopy, 54(4), 425-434.
  • 9. Cotton P. B. (1977). ERCP. Gut, 18(4), 316–341. https://doi.org/10.1136/gut.18.4.316
  • 10. Søreide K, Hallet J, Matthews JB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;107(10):1250-1261. doi:10.1002/bjs.11670
  • 11. Voiosu T, Voiosu A, Boškoski I, et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol. 2020;13:1756284820980671. Published 2020 Dec 21. doi:10.1177/1756284820980671
  • 12. Soetikno, R., Teoh, A. Y., Kaltenbach, T., Lau, J. Y., Asokkumar, R., Cabral-Prodigalidad, P., & Shergill, A. (2020). Considerations in performing endoscopy during the COVID-19 pandemic. Gastrointestinal endoscopy, 92(1), 176-183.
  • 13. Resál, T., Bor, R., Szántó, K., Fábián, A., Rutka, M., Sacco, M., Ribaldone, D. G., Molander, P., Nancey, S., Kopylov, U., Vavricka, S., Drobne, D., Lukas, M., Farkas, K., Szepes, Z., & Molnár, T. (2021). Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. Therapeutic advances in gastroenterology, 14, 17562848211006678. https://doi.org/10.1177/17562848211006678
  • 14. Tag-Adeen M, Yousef M, Osman H, et al. Impact of COVID-19 pandemic on endoscopic retrograde cholangiopancreatography; a single center experience [published online ahead of print, 2021 Oct 26]. Rev Esp Enferm Dig. 2021;10.17235/reed.2021.8229/2021. doi:10.17235/reed.2021.8229/2021
  • 15. John O’Grady, Jan Leyden, Padraic MacMathuna, Stephen Stewart & T. Barry Kelleher (2020) ERCP and SARS-COV-2: an urgent procedure that should be immune, Scandinavian Journal of Gastroenterology, 55:8, 976-978, DOI: 10.1080/00365521.2020.1789210
  • 16. Layton GR, Chung WY, Isherwood J, et al. Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units. Br J Surg. 2021;108(9):e290-e291. doi:10.1093/bjs/znab161
  • 17. Lauro A, Pagano N, Impellizzeri G, Cervellera M, Tonini V. Emergency Endoscopy During the SARS-CoV-2 Pandemic in the North of Italy: Experience from St. Orsola University Hospital-Bologna. Dig Dis Sci. 2020;65:1559–1561.
  • 18. Repici A, Pace F, Gabbiadini R, Colombo M, Hassan C, Dinelli M ITALIAN GI-COVID19 Working Group. Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy. Gastroenterology. 2020;159:363–366.e3.
  • 19. Kim KH, Kim SB. Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea: Retrospective survey. World J Clin Cases. 2021;9(28):8404-8412. doi:10.12998/wjcc.v9.i28.8404
  • 20. Donato G, Forti E, Mutignani M, et al. A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy. Endosc Int Open. 2021;9(4):E629-E634. doi:10.1055/a-1380-3419
  • 21. Kim KH, Kim SB, Kim TN. Changes in endoscopic patterns before and during COVID-19 outbreak: Experience at a single tertiary center in Korean. World J Clin Cases. 2021;9(15):3576-3585. doi:10.12998/wjcc.v9.i15.3576
There are 21 citations in total.

Details

Primary Language English
Subjects Surgery
Journal Section Research Article
Authors

İbrahim Ethem Cakcak 0000-0001-8885-514X

Merve Yaren Kayabaş 0000-0001-8136-2326

Sıla Cansız 0000-0003-2763-9261

Mustafa Numan Yılmaz 0000-0001-8510-8587

Doğan Albayrak 0000-0002-1950-2444

Publication Date October 1, 2022
Submission Date August 6, 2022
Published in Issue Year 2022Volume: 13 Issue: 4

Cite

EndNote Cakcak İE, Kayabaş MY, Cansız S, Yılmaz MN, Albayrak D (October 1, 2022) Covid-19: A Retrospective Study About The Challenges for ERCP?. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 13 4 470–475.